AGN News and Press, Allergan plc From 06/24/19

DUBLIN , June 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced CoolTone device received FDA clearance for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. CoolTone is also indicated for strengthening, toning and fi...

Karuna Therapeutics ( KRTX ) has filed to raise gross proceeds of up to $70 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing new therapeutics for debilitating neuropsychiatric conditions with high unmet medical needs. KRTX has a late 2019 pote...

The FDA has approved Allergan's (NYSE: AGN ) supplemental biologics application (sBLA) for BOTOX for the treatment of pediatric patients (2 to 17 years of age) with upper limb spasticity. More news on: Allergan plc, Healthcare stocks news, Read more ...

DUBLIN , June 21, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental biologics application (sBLA) for BOTOX ® for the treatment of pediatric patients (2 to 17 years of age) with uppe...

Stocks rose on Wednesday, bolstering their gains for the month, after the Federal Reserve opened the door for looser monetary policy in the near future. The Dow Jones Industrial Average finished positive 38.46 points to 26,504 The S&P 500 added 8.71 points to 2,926.46. The NAS...

Teva Pharmaceutical ( TEVA ) is a name which has seen continued tough times as it is dealing with a high debt load and massive sales pressure on its most important drug, as well as a generally not favourable pricing environment. While the company delivered on its 2018 plans, it is a soft...

Ironwood Pharmaceuticals (NASDAQ: IRWD ) and Allergan (NYSE: AGN ) report that Linzess (linaclotide) 290 mcg met its primary multi-component endpoint in a Phase IIIb study. More news on: Ironwood Pharmaceuticals, Inc., Allergan plc, Healthcare stocks news, Stocks on the move, Read mo...

– Phase IIIb study met all primary and secondary endpoints with statistical significance and demonstrated that linaclotide improved the overall abdominal symptoms of bloating, pain and discomfort in adults with IBS-C – – Results further support the efficacy and s...

Allergan (NYSE: AGN ) has jumped in recent minutes, up 3.2% , as Evercore ISI notes the company seems to be headed toward a split of its aesthetics and therapeutics business. More news on: Allergan plc, Healthcare stocks news, Stocks on the move Read more ...

THOUSAND OAKS, Calif. , June 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI ™ (trastuzumab-anns) for all approved indications of the reference product, Herceptin ®...